Outcome and toxicity of ifosfamide, carboplatin, and etoposide versus gemcitabine and vinorelbine regimen for pediatric patients with relapsed or refractory Hodgkin’s lymphoma

Outcome and toxicity of ifosfamide, carboplatin, and etoposide versus gemcitabine and vinorelbine regimen for pediatric patients with relapsed or refractory Hodgkin’s lymphoma

BackgroundPediatric classical Hodgkin lymphoma (CHL) is a curable disease; however, the optimal salvage regimen is unclear for relapsed/refractory (R/R) disease. This study aimed to compare response rates, toxicity, event-free survival (EFS), and overall survival (OS) of ifosfamide, carboplatin, and...

Full description

Bibliographic Details
Main Authors: Ahmed Mahdy, Asmaa Hamoda, Ahmed Zaher, Eman Khorshed, Madeha Elwakeel, Omneya Hassanein, Iman Sidhom
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Oncology
Subjects:
relapsed/refractory pediatric CHL
ICE
GV
toxicity
outcome
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1153128/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1153128/full

Similar Items